Miotens 0.25% 30 ml cutaneous foam

Miotens 0.25% 30 ml skin foam is an innovative solution for the topical treatment of muscle contractures and localized muscle pain . Formulated with 0.25% thiocolchicoside , this skin foam is indicated for the rapid and targeted relief of back pain (lumbosciatica), neck pain , shoulder pain and upper limb pain, as well as for cervico-brachial neuralgia , stubborn stiff necks and muscle stiffness due to trauma or surgery.

Thanks to its muscle relaxant and analgesic action , Miotens skin foam acts directly on the affected area, promoting the relaxation of muscle tension and reducing localized inflammation. The practical foam formulation allows for rapid absorption and uniform distribution of the active ingredient, making the product ideal for self-medication and topical treatment of acute or chronic muscle pain.

Miotens 0.25% 30 ml skin foam is particularly indicated for those who suffer from recurrent muscle tension , for athletes or for those who need effective support in the management of localized inflammation and post-traumatic or post-operative pain . Its composition, enriched with propylene glycol and other selected excipients, guarantees a feeling of immediate relief and a pleasant application on the skin.

Choose Miotens skin foam for a targeted and practical treatment of muscle contractures and joint pain , improving mobility and daily well-being.

ACTIVE INGREDIENTS

Active ingredients contained in Miotens 0.25% 30 ml skin foam - What is the active ingredient in Miotens 0.25% 30 ml skin foam?

100 ml, as a solution, contains: Active ingredient : thiocolchicoside 0.25 g Excipients: propylene glycol For the full list of excipients, see section 6.1

EXCIPIENTS

Composition of Miotens 0.25% 30 ml skin foam - What does Miotens 0.25% 30 ml skin foam contain?

Polysorbate 80, propylene glycol, ethyl alcohol, propylene glycol dipelargonate, benzyl alcohol, sodium phosphate monobasic monohydrate, sodium phosphate dibasic dodecahydrate, Lavender Nerolene, purified water. Propellant: propane-butane mixture (propane/n-butane/iso-butane).

DIRECTIONS

Therapeutic indications Miotens 0.25% 30 ml cutaneous foam - Why is Miotens 0.25% 30 ml cutaneous foam used? What is it used for?

Lumbosciatica (back pain), cervicobrachial neuralgia (pain and contracture affecting the neck, shoulder and upper limbs), obstinate stiff neck, post-traumatic and post-operative pain syndromes.

CONTRAINDICATIONS AND SIDE EFFECTS

Contraindications Miotens 0.25% 30 ml skin foam - When should Miotens 0.25% 30 ml skin foam not be used?

Hypersensitivity to the active substance or to any of the excipients. Flaccid paralysis, muscular hypotonia. Pregnancy and breastfeeding (see 4.6).

DOSAGE

Quantity and method of taking Miotens 0.25% 30 ml skin foam - How to take Miotens 0.25% 30 ml skin foam?

Apply a quantity of foam based on the size of the area to be treated 2-3 times a day. The treatment can be combined with physical rehabilitation therapies. Method of administration : shake before use and press the dispenser while holding the container upside down.

CONSERVATION

Storage Miotens 0.25% 30 ml skin foam - How should Miotens 0.25% 30 ml skin foam be stored?

MIOTENS CONTRACTURES AND PAIN 0.25% cutaneous foam: store away from heat. Contains flammable propellant. Do not expose to temperatures above 50°C.

WARNINGS

Warnings Miotens 0.25% 30 ml skin foam - It is important to know that about Miotens 0.25% 30 ml skin foam:

The dosage should be appropriately reduced in case of side effects. The use, especially if prolonged, of topical products can give rise to sensitization phenomena. If they occur, it is necessary to interrupt the treatment and institute appropriate therapy. MIOTENS CONTRACTURES AND PAIN contains propylene glycol: it can cause skin irritation.

INTERACTIONS

Interactions Miotens 0.25% 30 ml skin foam - Which medicines or foods can modify the effect of Miotens 0.25% 30 ml skin foam?

No notes.

SIDE EFFECTS

Like all medicines, Miotens 0.25% 30 ml skin foam can cause side effects - What are the side effects of Miotens 0.25% 30 ml skin foam?

Cases of rash and skin erythema have been reported. See also paragraph 4.4.

OVERDOSE

Overdose Miotens 0.25% 30 ml skin foam - What are the risks of Miotens 0.25% 30 ml skin foam in case of overdose?

No cases of overdose are known or have been reported in the literature.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Miotens 0.25% 30 ml cutaneous foam.

Although no teratogenic effect has been observed in animal studies except when thiocolchicoside was administered at doses much higher than those recommended in human therapy (more than 10 times the therapeutic dose), as a precaution, the use of the product is contraindicated during pregnancy. Since the drug passes into breast milk, its use during breastfeeding is not recommended.

DRIVING AND USE OF MACHINERY

Taking Miotens 0.25% 30 ml skin foam before driving or using machines - Does Miotens 0.25% 30 ml skin foam affect driving or using machines?

Although the onset of drowsiness after the administration of MIOTENS CONTRACTURES AND PAIN is to be considered a very rare occurrence, it is nevertheless necessary to take this possibility into account.